期刊文献+

3例伴基因重排及嗜酸性粒细胞增多的髓系/淋巴系肿瘤病例分析

Analysis of 3 Cases of Myeloid/lymphoid Tumors with Gene Rearrangement and Eosinophilia
下载PDF
导出
摘要 伴成纤维生长因子受体1、血小板衍生生长因子受体基因重排或中心粒旁物质1-Janus激酶2及嗜酸性粒细胞增多的髓系/淋系肿瘤是2016年世界卫生组织淋巴造血系统肿瘤分类中的独立疾病类型,其共同特征是融合基因的形成导致酪氨酸激酶异常表达,临床中较为罕见。该文报告3例伴基因重排及嗜酸性粒细胞增多的髓系/淋巴细胞系肿瘤病例,分析其临床表现、相关检查结果,以期为临床诊断和治疗提供参考。 Myeloid/lymphoid tumors associated with fibroblast growth factor receptor 1,platelet-derived growth factor receptor gene rearrangement or paracentriolar substance 1-Janus kinase 2 and eosinophilia is an independent disease type in the 2016 World Health Organization classification of lymphohematopoietic system tumors,whose common feature is that the formation of fusion genes leads to abnormal expression of tyrosine kinases,which is relatively rare in clinical practice.This article reports three cases of myeloid/lymphoid tumors with gene rearrangements and eosinophilia,and analyzes their clinical manifestations and related examination results,with a view to providing a reference for clinical diagnosis and treatment.
作者 石浩 段雅雅 卜欣婷 Shi Hao;Duan Yaya;Bu Xinting(Department of Hematology,Xuzhou Hospital Affiliated to Southeast University School of Medicine(Xuzhou Central Hospital),Xuzhou 221009,Jiangsu Province,China)
出处 《中国社区医师》 2024年第1期66-68,共3页 Chinese Community Doctors
关键词 基因重排 髓系肿瘤 淋巴系肿瘤 嗜酸性粒细胞 Gene rearrangement Myeloid neoplasms Lymphoid neoplasms Eosinophils
  • 相关文献

参考文献7

二级参考文献53

  • 1Bain BJ,Gilliland DG,Horny HP. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB and FGFR1[A].Lyon:iarc Press,2008.68-73.
  • 2Chase A,Grand FH,Cross NC. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome[J].Blood,2007,(10):3729-3734.
  • 3Cools J,DeAngelo DJ,Gotlib J. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinb in idiopathic hypereosinophilic syndrome[J].New England Journal of Medicine,2003,(13):1201-1214.
  • 4Griffin JH,Leung J,Bruner BJ. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome[J].Proceedings of the National Academy of Sciences(USA),2003,(13):7830-7835.
  • 5Yamada Y,Cancelas JA. FIP1L1/PDGFR alpha-associated systemic mastocytosis[J].International Archives of Allergy and Applied Immunology,2010,(Suppl 1):101-105.
  • 6Curtis CE,Grand FH,Musto P. Two novel imatinb-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia[J].British Journal of Haematology,2007,(01):77-81.
  • 7Zota V,Miron PM,Woda BA. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia[J].Journal of Clinical Oncology,2008,(12):2040-2041.doi:10.1200/JCO.2007.15.3841.
  • 8Klion AD,Robyn J,Akin C. Molecular remission and reversal of myelofibrosis in response to imatinb mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome[J].Blood,2004,(02):473-478.
  • 9Maric I,Robyn J,Metcalfe DD. KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities[J].Journal of Allergy and Clinical Immunology,2007,(03):680-687.
  • 10Lambert F,Heimann P,Herens C. A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint[J].Journal of Molecular Diagnostics,2007,(03):414-419.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部